- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02482142
The Role of Phosphorus in Diet Induced Thermogenesis (DIT) of Both Lean and Obese Subjects (PinDIT)
The Role of Phosphorus in Diet Induced Thermogenesis of Both Lean and Obese Subjects
The study aim at:
Investigating the impact of phosphorus ingestion on DIT of lean and obese subjects consuming high carbohydrate meal.
Investigating the impact of phosphorus ingestion on DIT of lean and obese subjects consuming high protein-low phosphorus meal.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Subject will be advice to take a weight maintenance diet which contains at least 250-300g of carbohydrate per day for the 3 days before each study day and also he/she will be asked to avoid any intense physical activity during the day before the day of the test. Overnight fasted subjects (> 8 hours) will be requested to attend the testing room at around 8:00 am. The he investigators will take the anthropometric measurements (weight, height, waist circumference) and determine blood glucose.
A crossover design study will be used in which each subject will undertake 2 or 3 sessions in a random order over 2 or 3 different days which are separated by a minimum of one week. The difference between the sessions is the ingestion of placebo ( 4 tablets) or phosphorus (4 tablets, each contain 125mgof phosphorus) tablets with the appropriate meal.
Specific Aim 1: The impact of phosphorus ingestion on DIT of lean and obese subjects consuming high carbohydrate meal (Table 1: Meal 1).
This will be divided into two experiments:
Experiment 1.1: The impact of phosphorus ingestion on DIT of lean subjects consuming high carbohydrate meal (16 subjects).
In this experiment, overnight fasted lean subjects (> 8 hours) will be requested to attend the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist circumference) will be taken, rest for 30 min, measure resting energy expenditure (REE) for 30 min, ingest meal with the appropriate supplement and measure postprandial energy expenditure (PEE) for 4 hours (see figure 3). In this experiment, subject will undertake 3 sessions in a random order over 3 different days which are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tablets) alone. No meal. Needed to determine the impact of phosphorus alone on DIT Session 2: Ingestion of phosphorus tablets (4 tablets) with the high carbohydrate meal (table1: Meal 1).
Session 3: Ingestion of placebo tablets (4 tablets) with the high carbohydrate meal (table 1: Meal 1).
Experiment 1.2: The impact of phosphorus ingestion on DIT of lean subjects consuming high carbohydrate meal (16 subjects).
In this experiment, overnight fasted obese subjects (> 8 hours) will be requested to attend the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist circumference) will be taken, rest for 30 min, measure resting REE for 30 min, ingest meal with the appropriate supplement and measure PEE for 4 hours (see figure 3). In this experiment, subject will undertake 3 sessions in a random order over 3 different days which are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tables) alone. No meal. Needed to determine the impact of phosphorus alone on DIT Session 2: Ingestion of phosphorus tablets (4 tables) with the high carbohydrate meal (Table 1:Meal 1).
Session 3: Ingestion of placebo tablets (4 tables) with the high carbohydrate meal (Table 1:Meal 1).
Specific Aim 2: The impact of phosphorus ingestion on DIT of lean and obese subjects consuming high protein-low phosphorus meal (table 1: Meal 2).
This will be divided into two experiments:
Experiment 2.1: The impact of phosphorus ingestion on DIT of lean and obese subjects consuming high protein-low phosphorus meal (16 subjects).
In this experiment, overnight fasted lean subjects (> 8 hours) will be requested to attend the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist circumference) will be taken, rest for 30 min, measure REE for 30 min, ingest meal with the appropriate supplement and measure PEE for 4 hours (see figure 3). In this experiment, subject will undertake 2 sessions in a random order over 2 different days which are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tablets) with the high protein meal (table1: Meal 2).
Session 2: Ingestion of placebo tablets (4 tablets) with the high protein meal (table 1: Meal 2).
Experiment 2.2: The impact of phosphorus ingestion on DIT of lean and obese subjects consuming high protein-low phosphorus meal (16 subjects).
In this experiment, overnight fasted obese subjects (> 8 hours) will be requested to attend the testing room at around 8:00 am. Anthropometric measurements (weight, height, waist circumference) will be taken, rest for 30 min, measure REE for 30 min, ingest meal with the appropriate supplement and measure PEE for 4 hours (see figure 3). Urine sample over the experimental period will be collected. In this experiment, subject will undertake 2 sessions in a random order over 2 different days which are separated by a minimum of one week.
Session 1: Ingestion of phosphorus tablets (4 tablets) with the high protein meal (table1: Meal 2).
Session 2: Ingestion of placebo tablets (4 tablets) with the high protein meal (table 1: Meal 2).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Beirut, Lebanon
- American University of Beirut
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- lean subjects (BMI between 20 and 25);
- obese (BMI above 30) subjects
Exclusion Criteria:
- Pregnant and lactating women
- Subjects on regular use of medication that affects body weight
- weight loss of 3% or more in the preceding 3 months
- Subjects with kidney disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: phosphorus alone
Effect of phosphorus (500mg) ingestion alone.
No meal.
Needed to determine the impact of phosphorus alone on DIT
|
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
|
|
Placebo Comparator: high CHO meal alone
Ingestion of placebo tablets with the high carbohydrate meal
|
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
|
|
Active Comparator: High CHO meal plus phosphorus
Effect of phosphorus (500mg) tablets ingestion of DIT of the high carbohydrate meal
|
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
|
|
Active Comparator: High protein meal plus phosphorus
Effect of phosphorus (500mg) tablets ingestion of DIT of the high protein meal
|
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
|
|
Placebo Comparator: High protein meal alone
Ingestion of placebo tablets with the high protein meal
|
Ingestion of 500mg of phosphorus ( 4 tablets, each of 125 mg of phosphorus)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in postprandial energy expenditure
Time Frame: 4 hours
|
Changes in area under the curve (AUC) of postprandial energy expenditure as measured by determining postprandial the volume oxygen consumption (VO2) and the volume of carbon dioxide production (VCO2)
|
4 hours
|
Collaborators and Investigators
Investigators
- Principal Investigator: Omar A Obeid, PhD, American University of Beirut Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- NUT.OO.22
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Effect of phosphorus
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Tufts...CompletedDietary Modification | Kidney Diseases, ChronicUnited States
-
University College CorkCork University Hospital; Irish Nutrition & Dietetic InstituteCompletedHyperphosphatemia | Dietary Modification | Renal DialysisIreland
-
Geisinger ClinicJohns Hopkins UniversityCompletedAlbuminuriaUnited States
-
American University of Beirut Medical CenterUnknownEnergy ExpenditureLebanon
-
Huashan HospitalCompleted
-
Massachusetts General HospitalShireCompletedChronic Kidney DiseaseUnited States
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Center for Molecular MedicineUnknownBrain and Central Nervous System TumorsUnited States
-
University Hospital, CaenWithdrawnInsulin Resistance | Type 2 DiabetesFrance
-
University of Texas Southwestern Medical CenterRecruitingChronic Kidney Disease Mineral and Bone Disorder | Chronic Kidney Disease (Stage 3-4)United States